Multivariate COX regression analysis showed that serum levels of IL-6 and glucocorticoid treatment were independent and protective factors, respectively, for the prognosis of severe COVID-19 patients with coexisting comorbidities (Table 3). This evidence concerns the gene IL6 and COVID-19.